Amryt loans from EIB for skin disorder gel aimed for $1.5 billion market
Amryt, the clinical-stage specialty pharmaceutical company focused on fighting rare and orphan diseases, has raised a five-year €20m loan with…
Pharmaceuticals, Biotechnology and Life Sciences
Amryt, the clinical-stage specialty pharmaceutical company focused on fighting rare and orphan diseases, has raised a five-year €20m loan with…
BD has announced a new research collaboration supported by JDRF, the global organization funding…
Bristol-Myers gets exclusive worldwide rights to develop Nitto’s investigational anti-fibrosis drug
The European Patent Office has issued a patent covering the Akers Biosciences’ Breath Ketone Detector, a single-use, non-invasive, breath device…
Probiodrug AG (Euronext Amsterdam: PBD), a biopharmaceutical company developing therapeutic solutions to treat Alzheimer’s disease, has finished the third quarter 2016…
GENFIT has signed an agreement for a NASH Registry Project
Horizon Discovery Group has entered into an Original Equipment Manufacturer (OEM) agreement with CareDx…
ristol-Myers Squibb Company and Infinity Pharmaceuticals have announced a clinical trial collaboration to evaluate Bristol-Myers Squibb’s Opdivo …
Dechra has appointed Lawson Macartney to the Board
Oxford Pharma’s OXPzero Ibuprofen going back into the clinic